Genomma Lab Internacional Sab De Cv operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genomma Lab Internacional Sab De Cv with three other
pharmaceutical manufacturers in Latin America:
sales of 2.66 billion Brazilian Reals [US$644.99 million]
of which 84%
was Diagnostic Medicine),
(3.72 billion Brazilian Reals [US$901.54 million]
Instituto Hermes Pardini SA
based in Brazil
(1.20 billion Brazilian Reals [US$291.62 million]
of which 53%
was Reference Labs).
During the year ended December of 2018, sales at
Genomma Lab Internacional Sab De Cv were 11.79 billion Mexican Pesos (US$616.26 million).
decrease of 2.4%
versus 2017, when the company's sales were 12.08 billion Mexican Pesos.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Genomma Lab Internacional Sab De Cv had sales
of 11.36 billion Mexican Pesos.